Aurobindo Pharma’s TheraNym Unit to Invest $175 Million in New Manufacturing Facility
Aurobindo Pharma’s specialty pharmaceutical arm TheraNym has announced plans to invest up to $175 million in establishing a new manufacturing facility, marking a significant expansion…